title: [Medullary carcinoma of the thyroid and 99mTc(V)-DMSA scintigraphy. Clinical results with a new radiopharmaceutical].
abstract: 99mTc(V)-DMSA scintigraphy is a non-invasive diagnostic tool for diagnostic differentiation and localisation of medullary carcinoma of the thyroid. For primary tumours its sensitivity is 77%. This diagnostic means is not only helpful for the diagnosis of primary tumours, but is especially informative for recidives and metastases of the medullary carcinoma of the thyroid. Its sensitivity for recidives and metastases is 66%. The sensitivity obtained in our study, which included four patients, corresponded to that reported in the literature.
authors.affiliation: Deutsche Klinik für Diagnostik, Wiesbaden.
authors.forename: C
authors.initials: C
authors.lastname: Kujat
authors.forename: K
authors.initials: K
authors.lastname: Neidl
authors.forename: C
authors.initials: C
authors.lastname: Müller-Leisse
mesh_terms: D000368:Aged; D002277:Carcinoma / Q000000981:diagnostic imaging*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D015609:Organotechnetium Compounds; D011877:Radionuclide Imaging; D012680:Sensitivity and Specificity; D004113:Succimer; D019783:Technetium Tc 99m Dimercaptosuccinic Acid; D013964:Thyroid Neoplasms / Q000000981:diagnostic imaging*
chemical_list: D015609:Organotechnetium Compounds; D019783:Technetium Tc 99m Dimercaptosuccinic Acid; D004113:Succimer
vernacular_title: Medulläres Schilddrüsenkarzinom und 99mTc(V)-DMSA-Szintigraphie. Klinische Ergebnisse mit einem neuen Radiopharmakon.